Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02469233 · ClinicalTrials.gov registry record · NA
A Transdiagnostic Sleep and Circadian Treatment to Improve Community SMI Outcomes
A NA study, sponsored by University of California, Berkeley.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
NCT02469233 is a NA study that has completed, run by University of California, Berkeley. The registered enrollment target is 121 participants.
The verdict
NCT02469233, a NA study, has completed, sponsored by University of California, Berkeley.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
Study Summary
Mental illness is often severe, chronic and difficult to treat. The sleep disturbance commonly experienced by individuals with a severe mental illness reduces capacity to function and contributes to key symptoms. This study seeks to determine if an intervention to improve sleep can improve functioning and reduce symptoms and impairment. The investigators will conduct this study in community mental health centers to ensure that the results contribute to closing the worrisome gap between research and practice and to ensure that the findings are generalizable to the real world.
Interventions
- BEHAVIORAL Transdiagnostic Intervention for Sleep and Circadian Dysfunction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2015-05 |
| Est. Completion | 2019-04-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02469233
The ClinicalTrials.gov registry entry for NCT02469233 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Berkeley, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transdiagnostic Intervention for Sleep and Circadian Dysfunction is the first listed.
NCT02469233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02469233 about?
NCT02469233 is a clinical study titled "A Transdiagnostic Sleep and Circadian Treatment to Improve Community SMI Outcomes". Mental illness is often severe, chronic and difficult to treat. The sleep disturbance commonly experienced by individuals with a severe mental illness reduces capacity to function and contributes to key symptoms. This study seeks to determine if an intervention to improve sleep can improve functioni...
What is the current status of trial NCT02469233?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2015-05. Estimated completion is 2019-04-17.
What interventions are being tested in trial NCT02469233?
The interventions under investigation include: Transdiagnostic Intervention for Sleep and Circadian Dysfunction (BEHAVIORAL).
Who is sponsoring clinical trial NCT02469233?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.